Proteomic Identification of Novel Plasma Biomarkers and Pathobiologic Pathways in Alcoholic Acute Pancreatitis. by Waldron, Richard T et al.
UCLA
UCLA Previously Published Works
Title
Proteomic Identification of Novel Plasma Biomarkers and Pathobiologic Pathways in 
Alcoholic Acute Pancreatitis.
Permalink
https://escholarship.org/uc/item/1195k268
Authors
Waldron, Richard T
Lugea, Aurelia
Gulla, Aiste
et al.
Publication Date
2018
DOI
10.3389/fphys.2018.01215
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
fphys-09-01215 August 29, 2018 Time: 10:36 # 1
ORIGINAL RESEARCH
published: 30 August 2018
doi: 10.3389/fphys.2018.01215
Edited by:
Steven Dooley,
Medical Faculty Mannheim,
Heidelberg University, Germany
Reviewed by:
Sarbjeet Makkar,
Washington University in St. Louis,
United States
Frank Tacke,
Uniklinik RWTH Aachen, Germany
Michael Chvanov,
University of Liverpool,
United Kingdom
Daniel Globisch,
Uppsala University, Sweden
*Correspondence:
Richard T. Waldron
waldronr@cshs.org
Specialty section:
This article was submitted to
Gastrointestinal Sciences,
a section of the journal
Frontiers in Physiology
Received: 12 May 2018
Accepted: 13 August 2018
Published: 30 August 2018
Citation:
Waldron RT, Lugea A, Gulla A and
Pandol SJ (2018) Proteomic
Identification of Novel Plasma
Biomarkers and Pathobiologic
Pathways in Alcoholic Acute
Pancreatitis. Front. Physiol. 9:1215.
doi: 10.3389/fphys.2018.01215
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Pathobiologic Pathways in Alcoholic
Acute Pancreatitis
Richard T. Waldron1* , Aurelia Lugea1, Aiste Gulla2,3 and Stephen J. Pandol1
1 Pancreatic Research Group, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States,
2 Department of Surgery, Georgetown University Hospital, Washington, DC, United States, 3 Department of Surgery, Vilnius
University Hospital Santaros Clinics, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
Acute pancreatitis (AP) is a painful and potentially life-threatening disorder with the
potential for therapeutic interventions. Biomarkers that characterize cases by severity
and pathogenic mechanisms involved are not yet available but needed for the
implementation of rational therapies. Here, we used shotgun proteomics to obtain
information from plasma samples about local and systemic pathologies taking place
during cases of alcoholic AP. Plasma was obtained at Kaunas University of Medicine
Hospital (Lithuania) from 12 AP patients of alcohol related etiology (median age of 40)
within 24 h of presentation, and 12 age-matched, healthy controls. Patients entered
into the study had moderately severe AP with the following characteristics: mean blood
lactate dehydrogenase level of 1127 mg/dl; median APACHEII score of 5.5 and mean
IMRIE score of 3.5. For proteomic analysis, less-abundant proteins in plasma samples
were enriched using Top 12 abundant protein depletion columns. Further processing
was performed by a modified filter-assisted sample preparation combined with tandem
mass tag labeling for quantitation. Samples were analyzed using an Orbitrap Elite mass
spectrometer for high resolution liquid chromatography–tandem mass spectrometry
(LC–MS/MS). Our analysis revealed 31 proteins that exhibited significant 1.5-fold or
higher increases in the AP compared to control patients, and six that were significantly
decreased. Gene ontology analysis indicated a strong correlation with exosomal origin
in the elevated proteins, with 29/31 (93.5%) associated with this extracellularly-secreted
compartment. Elevated proteins included established and proposed biomarkers of AP
including C-reactive protein, LPS-binding protein, intercellular adhesion molecule-1, and
von Willebrand factor, as well as several novel potential biomarkers. These results
provide the methodology for proteomic analysis of plasma samples to discover novel
biomarkers that characterize pancreatitis cases by pathogenic mechanism as well as
disease activity at an early stage that is highly informative for routine clinical practice and
clinical trials.
Keywords: acute pancreatitis, biomarkers, C-reactive protein, ethanol, Orbitrap Elite, proteomic, severity,
transketolase
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INTRODUCTION
Acute pancreatitis is one of the most common diseases of
the gastrointestinal tract, leading to tremendous emotional,
physical, and financial human burden (Papachristou et al., 2010).
In the United States, in 2009, AP was the most common
gastroenterology discharge diagnosis with a cost of 2.6 billion
dollars. Recent studies show the incidence of AP varies between
4.9 and 73.4 cases per 100,000 worldwide (Tenner et al., 2013).
Alcohol consumption has been identified as a primary cause of
both acute and chronic pancreatitis in most developed countries.
About one-third of AP in the United States is alcohol-related,
being more common in men, and the other most common
cause is gallstones (Dufour and Adamson, 2003). The relative
contribution of heavy alcohol consumption is likely to be greater
than gallstones for RAP, although this may vary based on the
demographic distribution. In Lithuania, as elsewhere in the
world, the detrimental effects of alcohol consumption on health
are of concern (Klumbiene et al., 2012). Alcohol does not
cause pancreatitis by itself but increases the susceptibility to
pancreatitis by affecting pancreatic physiology at multiple levels,
of which the most important is its ability to sensitize the pancreas
to other insults (Aframian et al., 1996; Pandol et al., 1999). One
such cofactor is smoking, which can also increase the risk of
pancreatitis independently (Andriulli et al., 2010; Greer et al.,
2015). Genetic susceptibility can explain an increased risk of
pancreatitis in some individuals who also drink.
Regardless of the environmental factors that accompany
and modify alcohol drinkers, AP related to alcohol tends to
exhibit significant organ damage and can be among the severe
cases with systemic inflammatory response syndrome (SIRS)
and organ failure involving the pulmonary, cardiovascular, and
renal systems (Ignatavicius et al., 2017). Single and combination
treatments to combat disorders in these organs have not been
developed for AP. Thus, early biomarkers of impending SIRS,
MODS, or infected necrosis in AP would be especially valuable.
Abbreviations: ACN, acetonitrile; AGT, angiotensinogen; ALB, serum albumin
precursor; AP, acute pancreatitis; APACHE, Acute Physiology and Chronic Health
Examination; BCA, bicinchoninic acid; C1, complement C1; C9, complement C9;
CRP, C-reactive protein; ERCP, endoscopic retrograde cholangiopancreatography;
ESCRT, endosomal sorting complex required for transport; F8, coagulation
factor VIII; FA, formic acid; FGA, fibrinogen alpha chain; FGB, fibrinogen beta
chain precursor; FGG, fibrinogen gamma chain precursor; GCR, glucocorticoid
receptor; IAP, intra-abdominal pressure; IL1, interleukin-1; IL6, interleukin-6;
IMRIE, modified Glasgow Imrie severity criteria for acute pancreatitis; IPA,
ingenuity pathway analysis; ITIH3, inter-alpha-trypsin inhibitor heavy chain 3;
LBP, lipopolysaccharide binding protein; LC–MS/MS, liquid chromatography–
tandem mass spectrometry; LDH, lactate dehydrogenase; LPS binding protein,
lipopolysaccharide binding protein; LRG1, leucine-rich alpha-2-glycoprotein 1;
MODS, multiple organ dysfunction syndrome; NFIL6, nuclear factor for IL-6
expression; ORM, alpha-1-acid glycoprotein 1; OSM, oncostatin M; RAP, recurrent
acute pancreatitis; RT, room temperature; S100A8, S100 calcium-binding protein
A8; SAA, serum amyloid A; SCX, strong cation exchange; SDS-PAGE, sodium
dodecylsulfate-polyacrylamide gel electrophoresis; SERPINA1, alpha-1-proteinase
inhibitor; SERPINA3, alpha-1-antichymotrypsin; SERPING1, plasma protease C1
inhibitor precursor; SIRS, systemic inflammatory response syndrome; SPARCL1,
secreted protein, acidic and rich in cysteine-like 1; TBS-T, Tris-buffered saline
supplemented with 0.075% Tween-20; TEAB, triethylammonium bicarbonate; TF,
transferrin; TKT, transketolase; TMT, tandem mass tag; TNF, tumor necrosis
factor; vWF, von Willebrand factor.
Scoring systems such as the Ranson’s, APACHE-II, and Imrie
systems have been used to help predict the severity level and
course of disease, but current trends have emphasized a desire in
the field to simplify these systems while retaining their predictive
performance (Papachristou et al., 2010; Wu et al., 2017). Many
stand-alone biomarkers have been proposed and evaluated over
the years, but very few have come into routine clinical practice,
either due to insufficient specificity or selectivity in the biomarker
or because inexpensive tests are not readily available. CRP, as
well as IL-6 have been found highly specific and selective, and
an inexpensive test has come into use for CRP (Meher et al.,
2015). This marker typically peaks at ∼72 h after the onset
of clinical AP and then subsides in mild, but not in severe
cases. Thus, CRP levels above ∼250 g/L indicate the presence
of a systemic inflammatory process such as AP. Improved
measures that evaluate the systemic effects of the disease and
identify targets for therapeutics are needed. Some experimental
therapeutic approaches are already under study and may prove
beneficial, but we do not have measures to determine pathways
they would affect during the disease. The ongoing development
of such measures is necessary, as these will need to be applied to
personalized treatment approaches.
Here, we performed a quantitative proteomic technique with
plasma proteins depleted of 12 abundant proteins to improve
coverage and digested with trypsin into peptides, which were
labeled with amino group-reactive tandem mass tags (TMT)
to facilitate quantitative determination of relative expression
levels in AP patients versus controls. Here, we report several
proteins significantly elevated or decreased in the AP compared
to the control subjects. Our findings substantiate the recent
development of CRP as a valid biomarker of AP that is
superior to more classic biomarkers such as pancreatic lipase.
While our data specifically adds validity to the use of CRP
as a biomarker of alcoholic AP, they also strongly implicate
acute phase proteins in general, as 16 distinct “positive acute
phase” proteins (SAA, ORM, AGT, LBP, CRP, FGA, FGB,
FGG, SERPINA3, F8, SERPINA1, C9, C1, ITIH3, vWF, and
SERPING1), and two “negative acute phase” proteins (Ritchie
et al., 1999) (ALB and TF) emerged in our list of proteins elevated
and decreased, respectively in alcoholic AP. In addition, several
proteins significantly elevated or decreased in AP patients that do
not correspond to the acute phase response may represent novel
AP biomarkers. Using our list of significantly altered proteins
in plasma, we also performed IPA to determine pathobiologic
regulatory pathways in AP patients.
MATERIALS AND METHODS
Study Design and Patient Population
These samples arise from a prospective observational study
conducted at the Department of Surgery at Kaunas University of
Medicine Hospital (Lithuania). Patients admitted during 2006–
2007 with a diagnosis of AP, history of significant alcohol intake
and onset of the disease within last 72 h were included in
this study (Dambrauskas et al., 2010). Plasma from healthy
controls was obtained during the same dates by the medical team
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using similar procedures used in patients. The Regional Ethics
Committee approved the study (Protocol Nos. BE-2-47 and P1-
113/2005) and all the patients and healthy controls provided
written informed consent. The AP diagnosis was established
on the basis of acute abdominal pain consistent with AP; and
at least threefold elevated levels of serum amylase or typical
radiological findings of AP. A contrast-enhanced CT scan was
performed on days 4 to 7 after onset of the disease to determine
the presence of pancreatic necrosis. Patients with underlying
chronic pancreatitis and patients with AP referred to the hospital
from other institutions after management for more than 3 days
were excluded from this study. Age- and sex-matched healthy
subjects (n = 18) without previous medical history were enrolled
as controls. Volunteers were excluded from participation on
the basis of the presence of any illness or any recent surgical
procedure.
Composite Clinical Scores
For each participant, the APACHE II scores were those calculated
on the day of admission. Similarly, the Marshall multiple
organ dysfunction syndrome (MODS) score reported was that
calculated initially. Severity was assessed according to the clinical
course and clinical scores (APACHE II > 7; Imrie-Glasgow > 2;
MODS > 2). Clinical data relating to the severity of disease,
development of organ dysfunction and/or septic complications
were prospectively collected in a standardized fashion. The
plasma sample Serum CRP and white blood cells were measured
to assess the inflammatory burden of the cohort.
Sample Acquisition and Handling
Peripheral blood samples from patients were drawn on admission
to the hospital and, after centrifugation, plasma samples were
stored at −80◦C until analysis. The blood samples of control
group underwent a similar process. Plasma samples were
transferred to Cedars-Sinai Medical Center, Los Angeles, CA,
United States where the proteomic analysis was performed.
All the procedures were approved by the Cedars-Sinai Medical
Center IRB, under protocol Pro00048082.
Plasma Depletion of Abundant Proteins
Selected AP and control plasma samples were thawed on ice,
vortexed to mix and centrifuged for 10 min at 14,000 rpm at
4◦C in a microfuge to float lipid and pellet any debris. Ten µl
of each cleared plasma was depleted of 12 Abundant proteins
using Proteome Purify 12 (R&D Biosystems) immunodepletion
resin (Krishnan et al., 2017) according to the manufacturer’s
instructions, and the recovered protein solution was acetone-
precipitated by combining with 5 volumes of acetone and storing
at −20◦C for 16 h. This process is designed to remove quantities
of α1-Acid Glycoprotein, α1-Antitrypsin, α2-Macroglobulin,
Albumin, Apolipoprotein A-I, Apolipoprotein A-II, Fibrinogen,
Haptoglobin, IgA, IgG, IgM and Transferrin, but also leaves
residual amounts of these proteins, as the removal is not
quantitative (not shown). Protein precipitate was recovered by
centrifuging at 14,000 rpm at 4◦C for 30 min, washed with 50%
acetone, centrifuged again and dissolved in 0.1 M Tris-HCl, pH
7.5 with 4% SDS. Protein concentrations were measured using a
BCA microassay and all samples adjusted to the lowest common
concentration, 0.7 µg/µl.
Filter-Assisted Sample Preparation
Combined With TMT Labeling (iFASP) for
Proteomic Analysis
Filter-assisted sample preparation (Wisniewski, 2017) was carried
out with the 12 AP samples and 12 controls, as follows: 90 µl (i.e.,
60 µg) of each sample was transferred to filter units (Millipore
Ultrafree-MC 30,000 Nominal Molecular Weight Limit, low
binding regenerated cellulose), the reducing agent TCEP was
added to 10 mM, and the tubes placed on a ThermoMixer and
heated to 55◦C for 1 h with occasional mixing. Then, 8 M
urea in 50 mM TEAB (UT) Buffer (300 µl) was added, the
samples inverted to mix, and buffer containing excess reducing
agent and SDS was depleted from the sample by centrifuging the
soluble components through the filter bed at 10,000 rpm on a
microfuge at RT. When samples in the filters reached ∼50 µl,
they were washed again with 300 µl UT Buffer. To alkylate
proteins, 50 mM iodoacetic acid was added. The samples were
mixed in the Thermomixer for 1 min, then placed in the dark for
30 min. One wash with UT buffer was followed by two washes
with 50 mM TEAB buffer (200 µl each). Proteomic-grade trypsin
(Thermo Fisher) was dissolved in the buffer provided (20 µl),
then combined with 50 mM TEAB, and 85 µl of this solution
was transferred to each filter to give a final trypsin:protein ratio of
1:40. The filters were sealed with Parafilm, then shaken at 600 rpm
with temperature set to 37◦C for 18 h.
Following trypsinization, sample volumes were measured, and
0.125 volume of each sample was removed and combined to
make a “master mix” or reference standard, which was divided
and transferred to three new filters. TMT labeling according
to the scheme shown in Figure 1 was performed according
to the manufacturer’s instructions, while peptides were still in
the columns, an innovation “iFASP” introduced by the Steen
lab (McDowell et al., 2013) to the established FASP method
(Wisniewski et al., 2009). Labeled peptides were then spun
through the filters, with extraction assisted by twice adding 40 µl
50 mM TEAB, shaking at 800 rpm for 20 min at 37◦C and
then spinning the filter tubes to collect labeled peptides in clean
LoBind tubes. A final extraction was done using 50 µl of 5 mM
NaCl in 50 mM TEAB. All peptides spun through the filter
were combined and the volume was reduced to ∼170 µl/tube by
vacuum centrifugation.
Samples were combined into three nine-plexes, according to
the scheme shown in Figure 1. The three nine-plexes of TMT-
labeled peptides were desalted using OASIS HLB columns by
loading in 1 ml 0.1% FA, washing 10 times with 1 ml, then
eluted once each with 30, 50, and 70% acetonitrile and combined.
ACN was removed by vacuum centrifugation. Peptides were then
fractionated using SCX spin columns (Thermo Fisher Scientific),
added to the columns in loading solution (LS) containing
0.1% FA/5% ACN. The flow through was kept as one fraction,
then after two washes with LS, further peptides were eluted
sequentially using a solution (S2) containing 0.1% FA, 0.5 M KCl
and 25% ACN, combined with LS at 25:75, 50:50 and 100:0 (i.e.,
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FIGURE 1 | Proteomic workflow for marker identification in alcoholic AP plasma samples. Samples were processed as described in Section “Materials and
Methods” and tryptic peptides labeled with amine-reactive tandem mass tags and assembled into nine-plexes as shown. Triplicates of a master mix of all peptides
were constructed, labeled with TMT-126 and incorporated into nine-plexes together with four controls and four alcoholic AP plasma samples. As there were 12
controls and 12 alcoholic AP plasma samples, three nine-plexes were needed. Each nine-plex was fractionated into four subfractions and then the 12 samples run
sequentially in the mass spectrometry experiment. Data were compiled, proteins identified and quantitated using Proteome Discoverer software. Bioinformatic
analysis was performed subsequently using online DAVID software and using IPA software licensed to CSMC and as described in the text.
undiluted S2). Fractions were desalted using disposable C18 spin
columns and stored at−20◦C.
LC–MS/MS and Systems Analysis of TMT
9-Plexes
The above SCX fractionation yielded four samples from each of
the three 9-plex peptide mixtures. These 12 mass spectrometry
samples were analyzed by high-resolution mass spectrometry as
follows: fractionated peptides were separated by low-pH RPLC
and analyzed by LC–MS/MS using an EASY-nLC 1000 connected
to an LTQ Orbitrap Elite Mass Spectrometer (Thermo Scientific).
Briefly, peptides were loaded onto a 2-cm trap column (PepMap
100 C18, 75 µm inner diameter, 3 µm particles, 100 Å pore
size) and separated by a 50-cm EASY-Spray column (PepMap
RSLC C18, 75 µm inner diameter, 2 µm particles, 100 Å pore
size) heated to 55◦C. For low-pH RPLC separation, the mobile
phase consisted of 0.1% FA in water (phase A) or acetonitrile
(phase B). The LC gradient was 4–24% B over 200 min, 24–
50% B over 20 min, and 50–100% B over 5 min at a flow
rate of 150 nL/min, followed by 100% B over 15 min at
a flow rate of 300 nL/min. Mass spectra were acquired in
a data-dependent manner, selecting up to 15 most abundant
precursor ions for higher-energy collisional dissociation. The
mass resolution for precursor and fragment ions were set at
120,000 and 60,000, respectively. The isolation width was set to
1.5 and the normalized collision energy was set to 40. Pierce BSA
Protein digest was used as standard for mass spec calibration.
All reagents used were mass spectrometry grade. Data were
analyzed using Proteome Discoverer (v2.1), with FDR set to
1% and proteins identified on the basis of at least two unique
peptides. Proteins identified were quantitated as the average of
four triplicate values generated between individual patients and
controls, given as the ratio patient/control as a fold change of
patient to control. Student’s t-test was performed and P-value of
0.05 taken as an indicator of significance. Further systems analysis
was also carried out by analyzing data using IPA1 (IPA, QIAGEN,
Inc.). IPA was performed by inputting a list of proteins elevated
and reduced, with associated fold-changes.
Human Pancreatic Acini and Pancreatic
Tissues
Human acini preparations and human pancreatic tissues were
used in this study. Primary human pancreatic acini were
obtained from cadaveric pancreatic tissues from organ donors.
Briefly, pancreata were digested at City of Hope (Duarte, CA,
United States) to separate islets from acinoductal trees, as
described (Qi et al., 2015). The resulting acini were transferred
to Cedars-Sinai Medical Center (Los Angeles, CA, United States)
and further prepared and characterized as previously described
(Lugea et al., 2017). The study was performed in accordance
with regulations and protocols approved by the Institutional
Review Boards of the Beckman Research Institute of the City of
Hope and the Cedars-Sinai Medical Center (IRB Pro00032114).
Briefly, normal pancreatic tissue samples were obtained from a
deceased organ donor and by surgical resection from a chronic
pancreatitis patient following approved institutional review
board procedures (Cedars-Sinai Medical Center, institutional
review board Pro00034086). Resected pancreas tissues were
examined at the Surgical Pathology Department. Normal tissue
samples were collected and snap frozen for subsequent analysis
or formalin fixed for histological examination to ensure normal
tissue morphology. Similar procedures were followed for tissue
sections from cadaveric pancreata.
Acini and pancreatic tissue samples were homogenized in
RIPA buffer containing 50 mmol/L Tris (pH 7.4), 150 mmol/L
1https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/
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NaCl, 1% deoxycholic acid, 1% Triton X-100, 0.1% SDS and a
mixture of protease and phosphatase inhibitors (Roche Applied
Science, Basel, Switzerland). Protein extracts were resolved by
Western Blot Analysis as indicated below.
Immunoprecipitation and Western Blot
Analysis
To analyze transketolase expression in human pancreas tissue
and acinar cells, samples of protein (20 µg/lane) were run
in Novex WedgeWell 4–20% Tris-glycine SDS-PAGE mini-
gels (Invitrogen). Proteins were separated by electrophoresis
and subsequently transferred to nitrocellulose membranes using
the XCell SureLock mini electrophoresis cell (Invitrogen).
Membranes were blocked with 5% non-fat dry milk in TBS-T and
incubated first with a rabbit anti-transketolase primary antibody
(sc-67120) from Santa Cruz Biotechnology (diluted 1:400 in
TBS-T, overnight at 4◦C), and then with an HRP-conjugated,
anti-rabbit secondary antibody (Cell Signaling Technologies), at
1:5000 for 1 h at RT and developed using Pierce SuperSignal
West Pico chemiluminescence substrate (Thermo Fisher) on
a Syngene PXi6 chemiluminescence documentation instrument
with GeneSys software. Protein loading control was estimated
using an antibody against β-actin (#A1978, Sigma-Aldrich).
The molecular weight of transketolase (68 kDa) was estimated
using Precision Plus dual color protein markers (Bio-Rad).
To analyze transketolase content of plasma, control or AP
patient plasma samples previously analyzed by quantitative
proteomics (chosen at random) were immunoprecitated using
the Catch and Release (v.2.0) Reversible Immunoprecipitation
System (Millipore), according to the manufacturer’s instructions.
Input protein per reaction included 11 µl of plasma (∼600 µg
protein) and 20 µl (i.e., 4 µg) of antibody sc-67120 in 500 µl
of dilution/wash solution. Incubation was carried out overnight
at 4◦C, and antibody capture effected using protein A-decorated
beads. After washing three times, beads were extracted with
gel-loading buffer, and captured transketolase protein was
analyzed by SDS-PAGE and Western blot analysis as described
above.
RESULTS
Clinical Data
Blood samples were obtained from patients admitted to the
hospital with a diagnosis of AP and an onset of the disease
within the last 72 h. The diagnosis of AP was made based
on typical abdominal pain, at least threefold elevated levels of
serum amylase, and typical radiological findings. Two of three
criteria were needed to make a diagnosis of AP, and peripheral
blood samples were drawn on admission. The severity of AP was
evaluated at 48 h after presentation.
For this study, we tested 12 human AP plasma samples.
The primary selection criteria were elevated LDH (>400 IU/L)
(see Table 1) and a history of alcohol abuse as an etiologic factor.
Patients with age < 20 or > 70 years-old were excluded. Age
and sex matched healthy subjects (n = 12) without previous
medical history were enrolled into the control group. Selected
AP patients were all males with alcohol as potential etiologic
factor (according to the patients self-reporting of alcohol abuse).
As indicated in Table 2, the average age of AP patients
was 40.3 year (median = 39.0); LDH levels, 1172.6 IU/L;
APACHE II score, 5.4; IMRIE score, 3.5; and MODS score, 3.3.
Average duration of treatment was 15.2 days (median = 16.5).
Complications included: IAP (27 mmHg) in one AP patient
that died during hospitalization; another patient had MODS,
heart failure and renal insufficiency; and two patients had
diabetes. No surgical interventions were needed; one patient
required ERCP, and two patients required ultrasound guided
drainage.
Proteomic Analysis Reveals Altered
Levels of Several Proteins in Plasma
From AP Patients Compared to Controls
The experimental design schematically illustrating the
composition of the multiplex proteomic sample labeling
with TMT and assembly into three nine-plexes is shown in
Figure 1. Tandem mass spectrometry and Proteome Discoverer
analysis identified 4217 peptides and 285 proteins. Many proteins
were changed in the AP patients relative to controls, as shown by
mean values of fold change returned by the analysis. To generate
a list of proteins increased or decreased, up to four determined
values were possible for each protein (i.e., one from each of
four fractions). The top proteins (by average fold change) as
shown in Figure 2A, often elevated in all four samples, were
analyzed by t-test. Fold-changes of 1.5-fold or more or 0.67-fold
or less were included, and we report here only those for which
P = 0.05 or less as a measure of statistical significance (Table 2).
A separate graphic in Figure 2B also depicts these proteins in
a circular fashion to highlight those with the highest elevated
levels.
TABLE 1 | Acute pancreatitis severity scores∗.
Number of patients Mean Standard deviation Median Minimum Maximum
Age (years) 12 40.3 10.4 39 25 66
LDH (U/L) 12 1172.6 735.6 1077.5 420.0 3028.0
APACHE II 12 5.4 4.1 5.5 0 11.0
IMRIE 12 3.5 1.8 3.5 1.0 6.0
MODS 12 3.3 2.7 3.0 0 10.0
∗For each participant, the scores were calculated at 48 h after presentation.
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TABLE 2 | Plasma markers of ethanolic AP from quantitative proteomics.
Accession Name/gene name MW (kDa) Unique peptides Coverage (%) Avg fold t-Test (P-value)
Proteins increased in alcoholic AP
P02741 C-reactive protein/CRP 25 8 28 7.48 0.00
P29401 Transketolase/TKT 68 3 6 6.29 0.00
P02750 Leucine-rich alpha-2-glycoprotein/LRG1 38 10 30 4.03 0.01
A0A096LPE2 Protein SAA2-SAA4/SAA2-SAA4 23 6 42 3.96 0.01
P05109 Protein S100-A8/S100A8 11 5 45 3.78 0.01
P06702 Protein S100-A9/S100A9 13 3 25 3.33 0.05
P01011 Alpha-1-antichymotrypsin/SERPINA3 48 21 43 3.10 0.00
Q08830 Fibrinogen-like protein 1/FGL1 36 3 13 3.08 0.02
P02679 Fibrinogen gamma chain/FGG 51 28 58 3.06 0.02
P02675 Fibrinogen beta chain/FGB 56 38 71 2.96 0.02
P02763 Alpha-1-acid glycoprotein 1/ORM1 23 5 35 2.91 0.01
P04275 von Willebrand factor/VWF 309 12 5 2.82 0.00
P01009 Alpha-1-antitrypsin/SERPINAI 47 28 66 2.71 0.01
P02671 Fibrinogen alpha chain/FGA 95 42 42 2.66 0.04
P0DJI8 Serum amyloid A-1 protein/SAA1 14 3 47 2.41 0.03
P13796 Plastin-2/LCP1 70 8 15 2.39 0.03
Q9UK55 Protein Z-dependent protease inhibitor/SERPINA10 51 5 10 1.98 0.00
P18428 Lipopolysaccharide-binding protein/LBP 53 6 14 1.86 0.01
P19652 Alpha-1-acid glycoprotein 2/ORM2 24 4 26 1.81 0.05
P07195 L-Lactate dehydrogenase B chain/LDHB 37 2 11 1.79 0.01
P00740 Coagulation factor IX/F9 52 8 17 1.78 0.00
P04040 Catalase/CAT 60 8 16 1.76 0.00
P08571 Monocyte differentiation antigen CD14/CD14 40 4 9 1.70 0.00
Q06033 Inter-alpha-trypsin inhibitor heavy chain H3/ITIH3 100 13 16 1.69 0.03
P02748 Complement component C9/C9 63 23 37 1.57 0.05
P05155 Plasma protease C1 inhibitor/SERPING1 55 14 26 1.54 0.01
P07998 Ribonuclease pancreatic/RNASEI 18 2 19 1.53 0.03
P00736 Complement C1r subcomponent/C1R 80 17 27 1.53 0.02
P01019 Angiotensinogen/AGT 53 8 18 1.50 0.02
Proteins decreased in alcoholic AP
P80108 Phosphatidylinositol-glycan-specific phospholipase D/GPLD1 92 11 13 0.63 0.01
P02775 Platelet basic protein/PPBP 14 3 26 0.61 0.02
Q9UGM5 Fetuin-B/FETUB 42 6 16 0.60 0.02
P02787 Serotransferri n/T F 77 48 58 0.54 0.02
P05154 Plasma serine protease inhibitor/SERPINA5 46 5 14 0.47 0.00
P02768 Serum albumin/ALB 69 76 87 0.46 0.02
Gene Ontology and Ingenuity Pathway
Analysis (IPA)
Gene Ontology analysis was performed using the 31 significantly
elevated or the six decreased proteins as input (Table 2).
Thus, according to analysis using the Database for Annotation,
Visualization and Integrated Discovery (DAVID) software
(Huang et al., 2009a,b) version 6.8, the major gene ontology
categories (Biological Processes, Cellular compartments and
Molecular Functions) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways detected are described in Figure 3.
Notable biological processes associated with proteins
elevated in AP samples include platelet degranulation, acute
phase response, blood coagulation, platelet activation, and
negative regulation of endopeptidase activity. Notable cellular
compartments associated with the elevated proteins include
exosomes, extracellular space, and platelet alpha granule lumen.
The most closely associated molecular function with the proteins
elevated in AP was serine-type endopeptidase inhibitor activity,
due to the presence of multiple SERPINs, ITIH3 and AGT, a
non-inhibitory member of the SERPIN family (Heit et al., 2013).
ITIH3 was recently reported as a PDAC serum biomarker (Liu
et al., 2017).
According to DAVID analysis, nearly all (29 of 31) the
increased proteins have been associated with or detected
in the cellular compartment of exosomes. Exosomes are
secreted particles initiated by invagination of late endosomal
boundary membrane and packaged by the ESCRT pathway into
multivesicular bodies. Overall, whereas the proteins increased
in ethanolic AP plasma corresponded to a wide range of blood
functions, compartments and processes, including ordinary
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FIGURE 2 | (A) Bar chart depicting proteins with quadruplicate elevated levels in alcoholic AP patient plasma. All proteins significantly elevated above 1.5-fold in AP
plasma in all four values returned by the analysis are presented with all of the individual values displayed. (B) Circular chart showing the same proteins with the
averaged values shown. The circular chart illustrates a gradual increase in the proteins closer to 1.5-fold, and big jumps to higher levels with a few outliers at the top
end of the fold-changes. Some proteins were also decreased in the analysis. Both increased and decreased proteins can be found in Table 2.
complement, fibrinolysis and blood coagulation components
normally secreted to the extracellular space, there is also evidence
of pathologic issues such as platelet degranulation and the
acute phase response, in addition to both innate and adaptive
immunity. We note that some of the proteins differentially
elevated or decreased in our TMT-based quantitative analysis
Frontiers in Physiology | www.frontiersin.org 7 August 2018 | Volume 9 | Article 1215
fphys-09-01215 August 29, 2018 Time: 10:36 # 8
Waldron et al. Plasma Biomarkers of Acute Pancreatitis
FIGURE 3 | (A) DAVID analysis results showing the major categories of gene ontology (GO) associated with the proteins elevated in alcoholic AP patient plasma.
A legend shows the categories, i.e., biological processes, cellular compartments, and molecular functions and KEGG pathways. (B) DAVID results showing the
associated GO categories associated with proteins decreased in the alcoholic AP patients’ plasma.
are among the 12 depleted proteins. These include α1-
antitrypsin/SERPINA1, Albumin and Transferrin. However, as
these proteins were depleted consistently from all samples, it is
unlikely that these differences arose from the depletion process
used in our sample preparation workflow. A recent article that
used the same abundant plasma protein removal procedure had a
similar conclusion (Krishnan et al., 2017).
We further extended our systems analysis of the ensemble of
proteins elevated and reduced in alcoholic AP by IPA analysis.
Proteins (Uniprot IDs) were input into the analysis together
with up or down fold-changes. Results of this analysis are
shown in Figure 4. IPA analysis predicted that many of the
acute phase proteins are synthesized via an upstream signal
transduction network involving cytokines such as TNFα, IL-1,
IL-6 and OSM, and key transcription factors such as STAT3 (see
Figure 4A). Other transcription factors such as NF-κB, AP-1 and
NF-IL6, and nuclear factors such as corticosteroid-GCR also play
important roles in the acute phase signaling pathway network
(data not shown). These signal transduction pathways initiated
in hepatocytes and other cells induce many downstream events
including chemotaxis, binding and invasion of inflammatory
cells, as shown schematically in Figure 4B. Elevation of genes
such as angiotensinogen and apolipoproteins E and C2 were also
predictive of upstream activation of LXR/RXR signaling (not
shown). A summary of the associated canonical pathways and
P-values as a measure of their relative statistical significance is
shown in Figure 4C. In AP, many other cytokines, chemokines,
and signaling molecules may also be involved in triggering
various responses which systematically account for SIRS and
organ failure (Dambrauskas et al., 2010). We anticipate that
insights into the upstream pathways triggering AP such as those
produced by IPA analysis will give rise to targeted treatments
for AP.
Validation of Selected Proteins Found
Elevated in Plasma From AP Patients
Compared to Controls
Among the distinct proteins found elevated in the AP samples
(shown in Figure 2 and Table 2), CRP had the highest fold-
change, measured as 7.5-fold higher in AP than control samples.
As mentioned above, CRP has been studied and found to be an
excellent indicator of AP severity, although it can be elevated in
other inflammatory conditions (Komolafe et al., 2017). Its use
in the clinic is increasing due to availability of an inexpensive
test (Meher et al., 2015), although its diagnostic accuracy may
depend on the timing and the clinical utility of CRP or other
biomarkers for prediction remains uncertain (Komolafe et al.,
2017). Whereas most of the proteins we found elevated in AP
are secreted proteins, the second highest protein, transketolase
is an intracellular enzyme. Leucine-rich α2 glycoprotein (LRG1)
has been identified as a marker of granulocyte differentiation,
is involved in neovascularization by altering TGFα signaling at
endothelial cells (Wang et al., 2013), and has recently been found
elevated in plasma associated with distinct cancers including
pancreatic (Capello et al., 2017). SPARC-like protein 1, also
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FIGURE 4 | Ingenuity pathway analysis cascading upstream cytokine and transcription factor regulatory pathways (A) and downstream pathobiologic effectors (B)
predicted from our proteomic dataset. Dark orange implies a predicted mediator or process. Red intensity shows expression level. (C) Major canonical pathways
associated with the gene set.
FIGURE 5 | Luminex determination of (A) CRP and (B) vWF in control and alcoholic AP patient plasma samples. Samples were thawed, diluted 40,000-fold as
instructed by the manufacturer, and processed further according to instructions. Readings were taken from duplicate measurements, and controls versus alcoholic
AP patient plasma results graphed with the mean and standard deviation shown by the horizontal lines with error bars; n = 9–10. Statistical significance was
evaluated by Student’s t-test. P-value for CRP measurement in AP patients was < 0.001. P-value for vWF was = 0.001.
known as HEVIN, is described as a matricellular protein, which
may have positive and/or negative roles in distinct cancers
(Gagliardi et al., 2017). S100A8, or calprotectin is a small calcium-
binding protein often associated with immune cells (Gebhardt
et al., 2006). Plastin-2 or Plastin-L/LCP1 is an actin-binding
protein associated with immune cells and may be elevated in
epithelial cells undergoing tumorigenesis (Shinomiya, 2012).
Among the other elevated proteins, one that has been widely
hypothesized to play distinct roles in pancreatic diseases is
angiotensinogen (Skipworth et al., 2011).
We also performed additional laboratory tests to reevaluate
the levels of CRP, as well as another acute phase protein
found elevated in the AP patients’ sera by quantitative mass
spectrometry, vWF. To achieve this, we performed Luminex
assays in a number of the same plasma samples analyzed by
quantitative LC–MS/MS. Shown in Figure 5A, CRP levels in all
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the AP plasma samples were dramatically elevated compared with
those in control plasma samples. Similarly, vWF levels were also
elevated, but to a lesser extent than CRP (Figure 5B). These data
indicate that a highly sensitive and exacting test such as Luminex
provides a similar series of elevated levels as that reported by
TMT labeling/LC–MS/MS, i.e., CRP > vWF. These data thereby
independently validate our finding of uniform elevation of these
two acute phase proteins in the AP patient plasma samples
analyzed.
Elevated plasma transketolase (TKT), to our knowledge has
not been previously reported as an AP biomarker. This enzyme
is normally not secreted, although it is expressed in pancreas
and may be released from damaged pancreatic tissue. Here, we
also performed Western blot analysis to detect TKT expression.
We first showed that a commercial antibody was successful to
detect TKT in samples of human pancreas tissue and isolated
human acinar cells (Figure 6). These data show the efficacy
of the antibody and the substantial expression in pancreas.
We next used the antibody to isolate elevated plasma TKT by
immunoprecipitation from a subset of proteomically analyzed AP
plasma samples. Thus, full length TKT was immunoprecipitated
from two control and two AP samples. Results of Western blot
analysis carried out with these immunoprecipitated samples,
shown in Figure 6 demonstrate that, whereas there is no
detectable TKT in control plasma immunoprecipitates, bands
selectively appear in AP samples. These data provide further
evidence which substantiates our finding of increased TKT in the
AP patients’ plasma by mass spectrometry.
DISCUSSION
The presence of elevated levels of proteins identified in this study,
including a significant number of acute phase response proteins
may be indicative of distinct disease processes and risk for severe
inflammatory disease complications and cancer. Further study
is needed to determine the specificity and selectivity of these
proteins as biomarkers in alcoholic AP. Acute phase proteins
appear to be well-suited to confirm the presence of systemic
inflammatory process in AP and individual proteins such as CRP
will likely continue to be used clinically. However, these proteins
may also be elevated in other disease processes, and therefore
they lack specificity. More novel is our finding of elevated
TKT, the cellular source of which is unknown. Measurement
of erythrocyte TKT activity has been used for many years as
a measure of thiamine deficiency (Thomson et al., 2010). Also,
erythrocyte abnormalities and hemolysis are known to occur in
alcoholics (Ballard, 1997). Further, another study found that TKT
protein can be diminished in hemolysates from alcoholic subjects
(Takeuchi et al., 1988). Taken together, these considerations
suggest erythrocytes as a possible source of elevated plasma TKT
in alcoholic AP patients.
However, our previous study undertaken with proteomic
analysis of normal human pancreas tissue also indicate that TKT
is highly expressed in pancreas (Lugea et al., 2017). Thus, excess
TKT in plasma could also be evidence of pancreas damage.
Further studies will be needed to evaluate whether TKT elevation
FIGURE 6 | Western blot analysis depicting the expression of transketolase
(TKT) in human pancreas and acinar cell samples (A) and as
immunoprecipitated from control versus alcoholic AP patients’ plasma (B). In
(A) approximately 20 µg of protein from each of two samples of human
pancreas homogenate (left) and two samples of human acinar cell samples
(right) were analyzed for TKT expression (upper panel). The same
representative blot was reprobed for β-actin as loading control (lower panel).
In (B) plasma samples (∼600 µg) were subjected to IP using 4 µg anti-TKT
antibody (n = 2). Arrows indicate the position of TKT.
is unique to alcoholic AP, is found more generally elevated in
AP, or is useful as a measure of predicted severity in these or
other patients. An important metabolic role was recently ascribed
to TKT to promote pancreatic cancer development through
conversion of fructose to nucleotides for anabolic metabolism
(Liu et al., 2010). Elevation of LRG1, SPARCL1, S100A8, Plastin-2
may be of special significance in a small but significant percentage
of patients which have increased risk for prolonged development
of a disease spectrum that connects AP, RAP, and chronic
pancreatitis with emergence of pancreatic cancer. Pancreatic
cancer exhibits profound alterations in neovascularization, which
likely precede and may even be pivotal in tumor initiation
in the context of CP. Thus, findings reported here may have
added significance in increasing our understanding of the poorly-
understood links between pancreatitis and pancreatic cancer.
The use of IPA as an adjunct to genomic and proteomic
investigations is rising steadily and has been included in over
2000 published papers in PubMed, 42 of which touch upon
some aspect of pancreas or pancreatic research. IPA relies on
a sophisticated, comprehensive manually curated information
base, a strength of which is its ability to factor in whether
the level of each gene increases or decreases. This allows data
to be integrated, interpreted, and displayed in the context
of previously documented biological pathways. In one study,
different oncogenes were introduced into a normal ductal cell
background, and IPA was used to understand which tumorigenic
pathways were initiated in the cells (Chang et al., 2013).
More recently, IPA was used to interpret effects of epigenetic
reprogramming in Mist1−/−mice (Mehmood et al., 2014). Here,
IPA showed that many of the proteins elevated during alcoholic
pancreatitis are those of the acute phase response. Beyond this,
some of the key transcription factors and chemokines/cytokines
involved were pinpointed, giving indications as to which
pathways are activated and might be targeted in future studies, or
even therapeutically. It has become clear that incorporating IPA
and other bioinformatic approaches into studies that generate
a set of genes or proteins has great potential to enhance our
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understanding of how normal biology is disrupted in disease
processes.
CONCLUSION
Given the wide range of outcomes in AP, and the failure of
clinical scoring systems to adequately prepare caregivers for
different outcomes in the AP disease course, much research
has been dedicated to identification of stand-alone protein
biomarkers which would be of value in assessing the severity of
AP patients. Nevertheless, whereas several potential markers of
severity including CRP have been tested to a limited extent, none
have been established as standards of care for this purpose. Here,
we used a shotgun proteomics approach to search for proteins
elevated or decreased in a small group of alcoholic AP patients
versus controls. This approach resulted in the identification of
CRP as the most elevated protein in these plasma samples,
which validates our approach since this is the protein most
often regarded as a valuable early AP biomarker. Other increased
proteins including transketolase are novel and will require further
study. Some proteins were also selectively decreased in alcoholic
AP samples in this study. These may also be significant in
pancreas diseases as well as in various other inflammatory
diseases.
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